ImmunoTarget Therapeutics, Inc.

IRVINE, CA · Biotech · Private

Therapeutic cancer vaccine derived from neoantigen-enhanced tumor lysates to stimulate patient T cell immunity against esophageal cancer

immunotarget.bio →
Grants
$355K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1291RIDGELINE THERAPEUTICS LLC——
1292BIOORG3.14 LLC——
1293SUNOMIX THERAPEUTICS——
1294ImmunoTarget Therapeutics, Inc.——
1295MEDISYNERGICS, LLC——
1296COMPOVAX, LLC——
1297MEDIKINE INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.